Nov 7, 2016
|
Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress
|
Oct 31, 2016
|
Ardelyx to Announce Third Quarter 2016 Financial Results on November 7, 2016
|
Oct 24, 2016
|
Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
|
Oct 19, 2016
|
Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting
|
Sep 22, 2016
|
Ardelyx to Present at Ladenburg Thalmann 2016 Healthcare Conference
|
Aug 15, 2016
|
Ardelyx to Present at Wedbush PacGrow Healthcare Conference
|
Aug 8, 2016
|
Ardelyx Reports Second Quarter 2016 Financial Results
|
Aug 1, 2016
|
Ardelyx to Report Second Quarter 2016 Financial Results on August 8th, 2016
|
Aug 1, 2016
|
Ardelyx Receives Notice of Allowance of Composition of Matter Patent Covering its Novel Potassium Binder RDX227675
|
Jul 15, 2016
|
Ardelyx to Raise $110 Million in a Private Placement
|